Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness, disability,...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantitative assessment of interstitial lung disease in rheumatoid arthritis.

Reumatologia clinica·2026
Same author

Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension.

Reumatologia clinica·2026
Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026
Same author

Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): An Official 2025 ALAT Clinical Practice Guideline.

Archivos de bronconeumologia·2026
Same author

Rheumatoid arthritis-associated interstitial lung disease (RA-ILD): Systemic disease activity correlates with lung inflammation.

Reumatologia clinica·2026
Same author

Impact of new regimens and drugs on rifampin-resistant tuberculosis management in Mexico.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2025
Same journal

Clinical validation of video DASH for upper limb disorders in rheumatic patients.

Reumatologia clinica·2026
Same journal

Coexistence of systemic lupus erythematosus and sarcoidosis: A case-based review.

Reumatologia clinica·2026
Same journal

Factors associated with the perception of body image in patients with psoriatic disease.

Reumatologia clinica·2026
Same journal

Anti-Mi-2-positive amyopathic dermatomyositis unveiled by a V-sign.

Reumatologia clinica·2026
Same journal

Antinuclear antibody detection beyond anti-dsDNA and anti-ENA: New insights from intact HEp-2 nucleus ELISA.

Reumatologia clinica·2026
Same journal

Long-term stability of autoantibody-based serological profiles in systemic lupus erythematosus.

Reumatologia clinica·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Epidemiology. Ethnic differences in systemic sclerosis].

Jorge Rojas-Serrano1

  • 1Instituto Nacional de Enfermedades Respiratorias. Tlalpan. México.

Reumatologia Clinica
|July 29, 2011
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis (SSc) shows varied prevalence and clinical features across ethnic groups. White populations exhibit lower incidence and distinct manifestations, potentially influencing survival rates.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Related Experiment Videos

Last Updated: May 30, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Area of Science:

  • Rheumatology
  • Immunology
  • Genetics

Context:

  • Systemic sclerosis (SSc) is a complex autoimmune disease with significant heterogeneity.
  • Ethnic variations in SSc epidemiology and clinical presentation are increasingly recognized.
  • Understanding these differences is crucial for personalized medicine and targeted research.

Purpose:

  • To conduct a comprehensive review of ethnic differences in systemic sclerosis.
  • To analyze variations in SSc epidemiology, clinical manifestations, and disease severity across diverse ethnic groups.
  • To explore potential factors contributing to observed ethnic disparities in SSc.

Summary:

  • White populations demonstrate lower incidence and prevalence of systemic sclerosis compared to other ethnic groups.
  • Whites present with a higher frequency of limited cutaneous disease and fewer inflammatory manifestations.
  • These epidemiological and clinical distinctions may contribute to survival differences between ethnic groups.

Impact:

  • Highlights the need for further research into the genetic and environmental factors underlying ethnic variations in SSc.
  • Informs clinical practice regarding ethnic-specific risk factors and disease trajectories.
  • Provides a foundation for developing culturally sensitive diagnostic and therapeutic strategies for systemic sclerosis.